Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
13 MG [14C]-A4250 capsule----3件: 93, 297, 338 💬
2A4250----4件: 93, 296, 297, 338 💬
3A4250-015----1件: 297 💬
4Atorvastatin1件: Atorvastatin2件: Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬17件: 13, 22, 46, 49, 51, 58, 79, 84, 88, 93, 96, 97, 160, 225, 271, 297, 299 💬
5Eicosapentaenoic acid1件: Icosapent1件: Icosapent 💬 --6件: 49, 96, 97, 296, 297, 338 💬
6LUM001----5件: 93, 94, 296, 297, 338 💬
7Magnesium gluconate2件: Magnesium,
Magnesium gluconate		1件: Magnesium gluconate 💬 --2件: 296, 297 💬
8Magnesium sulfate2件: Magnesium,
Magnesium sulfate		1件: Magnesium sulfate 💬 --3件: 11, 296, 297 💬
9Maralixibat1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬4件: 296, 297, 299, 338 💬
10Maralixibat (formely SHP625 or LUM001)1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬3件: 296, 297, 338 💬
11Maralixibat chloride1件: Maralixibat2件: Maralixibat ,
Maralixibat chloride 💬 		2件: SLC10A1,
SLC10A2 💬 		3件: Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬3件: 296, 297, 338 💬
12Odevixibat1件: Odevixibat1件: Odevixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬3件: 296, 297, 338 💬
13Phenylbutyrate1件: Phenylbutyric acid1件: Sodium phenylbutyrate 💬 --7件: 2, 93, 94, 244, 251, 297, 338 💬
14Questran1件: Cholestyramine1件: Cholestyramine resin 💬 --4件: 93, 254, 297, 338 💬
15TAK-625----2件: 297, 338 💬